Tom Appleton
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Early Adalimumab Induction for Immune Checkpoint Inhibitor Associated Inflammatory Arthritis (NCT06037811) | Tom Appleton | 2024-04-15 |
Track Tom Appleton automatically
Every clearance here is in the API, with alerts when new ones post.